SCHEMBL4786155

SCHEMBL4786155

O=P(O)(O)Oc1cccc(-c2c(OP(=O)(O)O)cc(OP(=O)(O)O)c(OP(=O)(O)O)c2OP(=O)(O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
INPPL1 O15357 12/20 0.51
INPP5A Q14642 6/20 0.51
INPP5B P32019 2/20 0.49
AKT1 P31749 1/20 0.47
SRC P12931 4/20 0.45
KDM4E B2RXH2 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
PDE3A Q14432 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
GGPS1 O95749 1/20 0.33
PLK1 P53350 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12005085 0.74 SRC (0.67) INPPL1INPP5AINPP5BSRCGPR84
SCHEMBL130697 0.73 INPPL1 (0.71) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL4186925 0.73 INPPL1 (0.71) INPPL1INPP5AINPP5BAKT1SRC
Biphenyl SCHEMBL18000012 0.72 SRC (0.69) INPPL1INPP5AINPP5BSRCKDM4E
Biphenyl SCHEMBL2780711 0.72 SRC (0.69) INPPL1INPP5AINPP5BSRCKDM4E
Phosphoric Acid SCHEMBL28992406 0.71 INPPL1 (0.68) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL10438537 0.70 INPPL1 (0.47) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL3727874 0.69 INPPL1 (1.00) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL7747354 0.69 SRC (0.58) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL28608140 0.68 SRC (0.45) INPPL1INPP5AINPP5BAKT1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008064244-A9 PHOSPHOINOSITIDE MODULATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIV COLUMBIA (US) 2008-08-21 WO claimed
WO-2008064244-A2 PHOSPHOINOSITIDE MODULATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-05-29 WO claimed